Completed
Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine
NCT04623034
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
Not specified